Pfizer News Monitoring

Pfizer's Dividend Yield Is 7.5%. Is It Still Safe?

A high dividend yield can be enticing, but it can also raise flags for income investors. Pfizer's falling valuation has pushed its yield up to well over 7%, which warrants a closer look. The company's payout ratio and free cash flow can help …

Buy Pfizer Stock For A Rebound After Crushing Q1 EPS Expectations?

Wednesday, April 30, 2025 2:10 AM EDT Image Source: Pixabay Pfizer (PFE - Free Report) shares spiked +3% in Tuesday’s trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations this morning. Still, Pfizer stock has fallen …

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth treatment areas: and that's weight loss. Analysts forecast a compound annual growth rate in the double digits from today over …

Pfizer Could Make ‘Tremendous Investments’ In The US, But Here’s Why It’s Choosing Not To

Tuesday, April 29, 2025 8:10 PM EDT Image Source: Unsplash Pfizer Inc. (PFE) chief executive Albert Bourla says uncertainty related to higher tariffs on pharmaceutical imports under the Trump administration is discouraging the company from investing in the …

Pfizer's CEO said the company could make 'tremendous investments' in the US if Trump's tariffs go away

Pfizer's CEO said President Donald Trump's tariffs and uncertainty are holding the company back from making "tremendous investments" in the US. In a first-quarter earnings call on Tuesday, chief executive Albert Bourla was asked what …

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development.  Bourla’s remarks on the company’s first …

Pfizer, in sweeping cost cutting push, lifts overall savings target to $7.7B

Pfizer is raising the bar for its sweeping cost-savings drive yet again, this time cranking up the total target to $7.7 billion through 2027. Of that total, $4.5 billion in net cost savings will be realized by the end of this year from an ongoing cost- …

Pfizer has unreasonable whiff of the Marlboro Man

After a pandemic surge, the vaccine maker’s stock crashed. A dividend now equal to 7.5% of its share price resembles tobacco giant Altria. Even amid recent uninspiring results, the implied dour outlook for a firm saving lives instead of ending them looks …

BridgeBio's Pfizer-Rivaling Heart Drug Just Obliterated Sales Expectations

BridgeBio's (BBIO) new heart drug, a rival to Pfizer's (PFE) blockbuster Vyndaqel, smashed sales expectations in its first full quarter on the market. During the three months ended March 31, Attruby brought in $36.7 million in U.S. sales, BridgeBio …

Pfizer faces investment roadblock in US due to tariffs uncertainty

Pfizer’s chief executive, Albert Bourla, told investors that the uncertainty surrounding President Donald Trump’s proposed tariffs on imported medicines is keeping the company from investing more in U.S. factories and research labs. Speaking during Pfizer’ …

Pfizer CEO Calls Trump’s Pharma National Security Concerns ‘Legitimate’

President Donald Trump’s national security concerns for the pharmaceutical supply chain are “legitimate,” Pfizer CEO Albert Bourla said Tuesday. The chief executive, who is also the chair of the PhRMA organization, noted that these concerns go back to …

Will Pfizer Stock Rebound After A Mixed Q1?

CANADA - 2025/04/03: In this photo illustration, the Pfizer logo is seen displayed on a smartphone ... More screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images …

Pfizer’s Bourla projects confidence that tariffs will focus on US adversaries

Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall

The Pfizer logo is seen outside the pharmaceutical company’s manufacturing plant, in Newbridge, Ireland February 10, 2025.  Clodagh Kilcoyne | Reuters Pfizer on Tuesday expanded its cost-cutting efforts and reported first-quarter profit that topped …

Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs

Pfizer will maintain its 2025 financial forecasts for now, but warned Tuesday it can’t predict the impact of any tariffs or trade policy changes the Trump administration might impose on the pharmaceutical sector. “While we continue to engage and plan for …

S&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit

Pfizer (PFE) stock jumped Tuesday after the S&P 500 drugmaker beat Wall Street's first-quarter profit expectations on the back of savvy cost-cutting measures. The company says it's on track to deliver $4.5 billion of net cost savings by the end …

Key highlights from Pfizer’s (PFE) Q1 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP net income decreased 5% to $2.96 billion, or $0.52 per share, compared to last year. Adjusted EPS increased 12% to $ …

'We should not have tariffs' on pharma: Pfizer CEO

Like his Big Pharma peers, Pfizer (PFE) CEO Albert Bourla is waiting for the US government to finalize its decision on whether to place a 25% tariff on pharmaceutical imports. To be sure, he said Tuesday, the government's national security concerns are …

Crude Oil Down Over 2%; Pfizer Shares Gain After Q1 Earnings

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 250 points on Tuesday. The Dow traded up 0.70% to 40,507.41 while the NASDAQ rose 0.30% to 17,417.49. The S&P 500 also rose, gaining, 0.37% to 5,548.98. Check This …

Nonprofit Launches Ketogenic Metabolic Therapy for Psychiatric Disability

Nonprofit provides ketogenic metabolic therapy education and support, removing barriers to psychiatric recovery for individuals on disability. VANCOUVER, WA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- A nonprofit is expanding access to …

The Rise of Intelligent Tech in Addiction Recovery: Bridging Traditional Support with Digital Innovation

Innovative tech is transforming treatment for substance use disorders, enhancing support, recovery, and accessibility through smart solutions. ATLANTA, GA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- The landscape of addiction recovery …

MeTime Healing Receives $125,000 Technology Innovation Grant to Advance AI-Powered Mental Health Platform

Digital platform aims to reduce stigma, strengthen emotional resilience, and build community through culturally responsive mental health support GAITHERSBURG, MD, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- MeTime Healing LLC, a …

Introducing Hydrowave - New Healthcare Technology to Break the Chronic Pain Cycle

Natural Tissue Regeneration and Stem Cell Therapy Now Available in Ottawa OTTAWA, ONTARIO, CANADA, April 30, 2025 /⁨EINPresswire.com⁩/ -- Chronic pain sufferers in Ottawa now have access to a new healthcare technology that is transforming pain management …

Announcing The Hero’s Recharge: Mind-Body-Mission Fundraiser Event

A Wellness Event for First Responders to Combat Stress & Build Resilience SHREWSBURY, NJ, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- Bridging the Gap Between Mental Health and First Responder Culture Every siren tells a story. …

SHAPING THE FUTURE OF WORK: ERGOTRON’S LX PRO DESK MONITOR ARM EMPOWERS APAC PROFESSIONALS WITH ERGONOMIC INNOVATION

Ergotron launches the LX Pro Desk Monitor Arm to support Asia Pacific’s return-to-office trends, boosting comfort, productivity, and workplace well-being. SINGAPORE, SINGAPORE, April 30, 2025 /⁨EINPresswire.com⁩/ -- SINGAPORE, 29 APRIL 2025 – As …

Successful relaunch of the DSMZ online shop: Microorganisms and cell cultures for the world

Leibniz Institute DSMZ relaunches web shop and includes analyses and services in its digital portfolio BRAUNSCHWEIG, GERMANY, April 30, 2025 /⁨EINPresswire.com⁩/ -- A few days ago, the online shop of the Leibniz Institute DSMZ-German Collection of …

Dengue Fever Treatment Market Explosive Growth: A Deep Dive into Trends, Innovations, and Country-Wise Insights | FMI

Dengue Fever Treatment Market outlook from 2025 to 2035, highlighting growth trends, key players, and innovations driving global healthcare advancements. NEWARK, DE, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- The dengue fever treatment …

Empowering Communities: Magnolia Dental Waterdown's Commitment to CDCP Outreach Programs

Magnolia Dental Waterdown enhances access to quality care through CDCP support, championing affordable dentistry and community-focused oral health programs. WATERDOWN, ONTARIO, CANADA, April 30, 2025 /⁨EINPresswire.com⁩/ -- Magnolia Dental …

Diamond-Blackfan Anemia Syndrome Therapeutics Market to Reach USD 7,860 Million by 2035 grow at a CAGR of 4.2% | FMI

Diamond-Blackfan Anemia Syndrome therapeutics market outlook 2035 focuses on treatment advancements, market trends, and growth projections in the sector. NEWARK, DE, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- The global diamond-blackfan …

BioFlex Appoints Bill Cook to Board of Advisors

PHOENIX, AZ, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- BioFlex, a leading provider of innovative healthcare solutions, is pleased to announce the appointment of Bill Cook to its Board of Advisors. Mr. Cook brings over two decades of …

Enamine and Pohang Accelerator Laboratory Partner to Speed Up Fragment-Based Discovery Projects

KYIV, UKRAINE, April 30, 2025 /⁨EINPresswire.com⁩/ -- Enamine, the leading provider of chemical compounds and drug discovery services, and Pohang Accelerator Laboratory (PAL), a science and technology institution in South Korea, have signed a …

Dr Karthik Ram, Pioneer of Cosmetic Surgery in Chennai, Wins 2025 ThreeBestRated® Award for Transforming People’s Lives

CHENNAI, TAMIL NADU, INDIA, April 30, 2025 /⁨EINPresswire.com⁩/ -- Dr. Karthik Ram, MBBS, DNB, MRCS, one of Chennai's leading cosmetic surgeons, celebrates his seventh consecutive year as a top plastic surgeon on ThreeBestRated®, cementing his …

UCSF Rosenman RISE Program Welcomes the 2025 Class of Health Innovators

Supporting bold ideas in healthcare through mentorship, community, and commitment to turning bold ideas into life-changing realities. SAN FRANCISCO, CA, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- The UCSF Rosenman RISE Program—one of …

Hunterdon Hematology Oncology Physicians Awarded As 2025 NJ Top Docs

NJ Top Docs has reviewed and approved five physicians at Hunterdon Hematology Oncology for 2025. FLEMINGTON, NJ, UNITED STATES, April 30, 2025 /⁨EINPresswire.com⁩/ -- NJ Top Docs has reviewed and approved five physicians at Hunterdon Hematology …

GenesWell BCT 可以对Oncotype DX 低风险乳腺癌患者进行再分类

SEOUL, SOUTH KOREA, April 30, 2025 /⁨EINPresswire.com⁩/ -- GENCURIX 宣布一项多中心研究结果，评估其乳腺癌预后检测产品 GenesWell BCT 与广泛使用的 21 基因表达检测 Oncotype DX 在预后评估能力方面的表现。 这项回顾性研究纳入了来自韩国五家医疗机构的 759 名早期激素受体阳性、HER2阴性（HR+/HER2- …

GenesWell BCT、Oncotype DXで低リスクと分類された患者の一部を再分類できる

SEOUL, SOUTH KOREA, April 30, 2025 /⁨EINPresswire.com⁩/ -- ジェンキュリックス（GENCURIX）は、同社の乳がん予後検査「GenesWell BCT」と、広く使用されている 「Oncotype DX」(21遺伝子発現検査)の予後リスク分類性能を比較した多施設共同研究の結果を発表しました。 この後ろ向き研究には、韓国の5 …

Bee Choo Origin Celebrates Over Two Decades of Pioneering Natural Herbal Hair Care Solutions in Southeast Asia

KUALA LUMPURS, MALAYSIA, April 30, 2025 /⁨EINPresswire.com⁩/ -- Bee Choo Origin, a trailblazer in natural herbal-based hair and scalp care, marks more than 20 years of delivering trusted solutions for hair loss and scalp health. Established as one of …

TrainingPros Named a 2025 Top 20 Staffing and Temporary Resources Company by Training Industry

TrainingPros, a leading provider of contract staffing for (L&D) professionals, has been named a Top 20 Staffing Company for 2025 by Training Industry. ATLANTA, GA, UNITED STATES, April 29, 2025 /⁨EINPresswire.com⁩/ -- This honor reflects …

Er-Kim Announces Exclusive Distribution Agreement with Puma Biotechnology to Commercialize NERLYNX® (neratinib) for ...

ATHENS, Greece and LOS ANGELES, April 30, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in the EMEA region, today announced that it has signed an agreement with Puma …